New insider Seven Fleet Capital Management Lp claimed ownership of 80,000 shares (SEC Form 3)
$MANE
Biotechnology: Pharmaceutical Preparations
Health Care
| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
(Country) | 2. Date of Event Requiring Statement
(Month/Day/Year) 05/01/2026 | 3. Issuer Name and Ticker or Trading Symbol
Veradermics, Inc [ MANE ] | |||||||||||||||
| 3a. Foreign Trading Symbol
| 5. If Amendment, Date of Original Filed
(Month/Day/Year) | ||||||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| 6. Individual or Joint/Group Filing (Check Applicable Line)
| ||||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock, $0.00001 par value per share | 80,000 | I(1) | By Managed Funds(1) |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Explanation of Responses: |
| 1. This Form 3 is being filed by Seven Fleet Master Fund LP, a limited partnership organized under the laws of the Cayman Islands ("Seven Fleet Master Fund"), Seven Fleet Capital Management LP, a limited partnership organized under the laws of the State of Delaware ("Seven Fleet Management"), Seven Fleet Capital Management GP LLC, a limited liability company organized under the laws of the State of Delaware ("Seven Fleet Management GP" and together with Seven Fleet Master Fund and Seven Fleet Management, the "Reporting Entities") and Dr. Brian Liu. Dr. Liu may be deemed to control the Reporting Entities and therefore may be deemed to beneficially own shares of Common Stock held by the Reporting Entities. Dr. Liu disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of any indirect pecuniary interest therein. |
| Seven Fleet Master Fund LP By: Seven Fleet Capital Management LP, its Investment Manager By: Seven Fleet Capital Management GP, LLC, its General Partner /s/ Dr. Brian Liu Managing Member | 05/05/2026 | |
| Seven Fleet Capital Management LP By: Seven Fleet Capital Management GP, LLC, its General Partner /s/ Dr. Brian Liu Managing Member | 05/05/2026 | |
| Seven Fleet Capital Management GP LLC /s/ Dr. Brian Liu Managing Member | 05/05/2026 | |
| Brian Guan-Chyun Liu /s/ Dr. Brian Liu Managing Member | 05/05/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
| * Form 3: SEC 1473 (03-26) | ||